Geode Capital Management »

Cartesian Therapeutics shares owned by Geode Capital Management

Quarter-by-quarter ownership of Cartesian Therapeutics (RNAC) shares owned by Geode Capital Management from 13F filings

Historical chart of Geode Capital Management investment in Cartesian Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cartesian Therapeutics held by Geode Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cartesian Therapeutics by Geode Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.2M 136k 16.12
2024-06-30 $3.6M 133k 27.01